Developer docs
API playgroundTry for free, no card

Search company profiles

Bioarray

Full company profile

uuid000tmg1

Namestring
Bioarray
Websiteurl
bioarray.es
Company typeenum
Private
Founded yearint
2008
Descriptiontext

Bioarray is a private Spanish biotechnology company headquartered in Elche, Spain, founded in 2008 and operating with a headcount of 11-50 employees. Its self-stated mission is to provide molecular diagnosis of genetic diseases, positioning it within the clinical molecular diagnostics segment and implying a customer base of healthcare providers, clinical laboratories, and patients with suspected hereditary conditions.

The company's website (bioarray.es) returned only a loader/verification page during data collection, and no information on core products, assay or platform technology, service catalog, regulatory certifications, or pricing structure is documented in the available source material. There is no disclosed funding history, leadership roster, scientific advisory board, partnership ecosystem, patent portfolio, or customer reference list.

No revenue, headcount trend, geographic footprint beyond Elche, or commercial pipeline data is available, so the company's scale, growth posture, and competitive positioning within the Spanish and broader European molecular diagnostics market cannot be assessed from the present evidence base.

Short descriptiontext

Bioarray is a private Spanish molecular diagnostics company headquartered in Elche, Spain, founded in 2008. With 11-50 employees, its stated mission is to provide molecular diagnosis of genetic diseases, serving healthcare providers and patients in the clinical genetics segment.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersElche, Spain
HQ citystring
Elche
HQ countrystring
Spain
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
molecular diagnostics, genetic disease testing, clinical genomics, DNA diagnostics services, hereditary disease screening
Industry5 codes
PRIMARYHLAFAMAE
Molecular Diagnostics & Genomics Laboratories
SECONDARYHLAAALAA
Molecular Diagnostics (PCR/qPCR, NGS-based assays)
SECONDARYHLAAALAD
Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics)
SECONDARYHLAGADAF
Molecular & Genetic Testing (PCR/NGS/qPCR)
SECONDARYHLAAALAL
Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays)
NAICS code1 code
  • Medical Laboratories621511
SIC code1 code
  • Services-Medical Laboratories8071
Product category
Molecular Diagnostics
Cost components4 values
Personnel, Operations, Technology or R&D, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Bioarray provides molecular diagnosis of genetic diseases. The company operates as a small laboratory services provider focused on identifying and characterizing hereditary and genetic disorders through molecular-level testing. Specific assay menus, panels, or service workflows are not detailed in the available source material.

Differentiator
Functional benefit
Problem solved
No data
Peers10 records
TypeBroad incumbent
Description

US molecular diagnostics company offering cell-free DNA, reproductive, and oncology genetic testing. Operates in overlapping molecular diagnostic categories but with far greater scale and commercial reach than Bioarray.

TypeBroad incumbent
Description

Large US molecular diagnostics company with a broad hereditary disease, oncology, and pharmacogenomic test menu. Comparable as an established molecular diagnostics incumbent, though significantly larger and broader in scope than Bioarray.

TypeDirect peer
Description

Germany-headquartered rare disease and molecular diagnostics company offering genetic testing and interpretation services. Comparable as a European molecular diagnostics lab focused on hereditary disease, overlapping with Bioarray's core mission.

TypeEmerging player
Description

Genetics company offering whole-genome and molecular genetic testing with a focus on hereditary disease prevention. Comparable as a genetic disease diagnostics player, though focused on whole-genome sequencing rather than array-based testing.

5Sistemas Genómicos
TypeDirect peer
Description

Spanish molecular genetics laboratory offering cytogenetic and molecular diagnostic services, including hereditary disease testing. Closely comparable to Bioarray as a domestic Spanish peer in molecular genetic diagnostics.

TypeBroad incumbent
Description

European genomics services arm of Eurofins Scientific offering molecular biology, sequencing, and genotyping services. Comparable as a European molecular/genetic testing services provider within a much larger industrial group.

7Medicover Genetics
TypeRegional player
Description

European clinical genetics laboratory (part of Medicover) offering molecular and cytogenetic diagnostic services across Central and Eastern Europe. Comparable as a regional molecular diagnostics provider with a hereditary disease focus.

TypeBroad incumbent
Description

US-based genetic testing company offering a broad menu of molecular diagnostics across hereditary conditions, reproductive health, and oncology. Comparable as a molecular diagnostics provider, though operating at substantially greater scale.

9Reference Laboratory S.L.
TypeDirect peer
Description

Spanish reference diagnostics laboratory providing specialized molecular and genetic testing to clinicians and hospitals. Directly comparable as a Spain-based molecular diagnostics service provider.

TypeDirect peer
Description

Spain-based reproductive and clinical genetics laboratory (now part of Vitrolife) offering molecular diagnostics in reproductive health and hereditary disease. Direct peer due to overlapping molecular genetic testing services and Spanish footprint.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat1 record

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Bioarray

Molecular Diagnosticsbioarray.es

Bioarray is a private Spanish molecular diagnostics company headquartered in Elche, Spain, founded in 2008. With 11-50 employees, its stated mission is to provide molecular diagnosis of genetic diseases, serving healthcare providers and patients in the clinical genetics segment.

What Bioarray does

Bioarray is a private Spanish biotechnology company headquartered in Elche, Spain, founded in 2008 and operating with a headcount of 11-50 employees. Its self-stated mission is to provide molecular diagnosis of genetic diseases, positioning it within the clinical molecular diagnostics segment and implying a customer base of healthcare providers, clinical laboratories, and patients with suspected hereditary conditions.

The company's website (bioarray.es) returned only a loader/verification page during data collection, and no information on core products, assay or platform technology, service catalog, regulatory certifications, or pricing structure is documented in the available source material. There is no disclosed funding history, leadership roster, scientific advisory board, partnership ecosystem, patent portfolio, or customer reference list.

No revenue, headcount trend, geographic footprint beyond Elche, or commercial pipeline data is available, so the company's scale, growth posture, and competitive positioning within the Spanish and broader European molecular diagnostics market cannot be assessed from the present evidence base.

Bioarray firmographics

Firmographics
Name
Bioarray
Website
https://bioarray.es
Company type
Private
Founded year
2008
Operating status
Operating
Headcount range
51–100 employees
Short description
Bioarray is a private Spanish molecular diagnostics company headquartered in Elche, Spain, founded in 2008. With 11-50 employees, its stated mission is to provide molecular diagnosis of genetic diseases, serving healthcare providers and patients in the clinical genetics segment.
Ownership category
akta.pro rank

Bioarray industry classification

Industry
Product category
Molecular Diagnostics
NAICS
Medical Laboratories (621511)
SIC
Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLAFAMAE
Molecular Diagnostics & Genomics Laboratories
SECONDARYHLAAALAA
Molecular Diagnostics (PCR/qPCR, NGS-based assays)
SECONDARYHLAAALAD
Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics)
SECONDARYHLAGADAF
Molecular & Genetic Testing (PCR/NGS/qPCR)
SECONDARYHLAAALAL
Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays)

Keywords

  • Molecular diagnostics
  • Genetic disease testing
  • Clinical genomics
  • DNA diagnostics services
  • Hereditary disease screening

Where Bioarray is headquartered

Location

Headquarters

HQ city
Elche
HQ country
Spain
HQ region
Europe

Markets served

Bioarray business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure

Bioarray product offering

Product offering

Core offering

Bioarray provides molecular diagnosis of genetic diseases. The company operates as a small laboratory services provider focused on identifying and characterizing hereditary and genetic disorders through molecular-level testing. Specific assay menus, panels, or service workflows are not detailed in the available source material.

Differentiator

Problem solved

Functional benefit

Companies that use Bioarray

Customer profile

Ideal customer profiles1 record

Bioarray technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Bioarray competitors and assessment

Company assessment

Broad incumbents

  • Natera: US molecular diagnostics company offering cell-free DNA, reproductive, and oncology genetic testing. Operates in overlapping molecular diagnostic categories but with far greater scale and commercial reach than Bioarray.
  • Myriad Genetics: Large US molecular diagnostics company with a broad hereditary disease, oncology, and pharmacogenomic test menu. Comparable as an established molecular diagnostics incumbent, though significantly larger and broader in scope than Bioarray.
  • Eurofins Genomics: European genomics services arm of Eurofins Scientific offering molecular biology, sequencing, and genotyping services. Comparable as a European molecular/genetic testing services provider within a much larger industrial group.
  • Invitae: US-based genetic testing company offering a broad menu of molecular diagnostics across hereditary conditions, reproductive health, and oncology. Comparable as a molecular diagnostics provider, though operating at substantially greater scale.

Direct peers

  • Centogene: Germany-headquartered rare disease and molecular diagnostics company offering genetic testing and interpretation services. Comparable as a European molecular diagnostics lab focused on hereditary disease, overlapping with Bioarray's core mission.
  • Sistemas Genómicos: Spanish molecular genetics laboratory offering cytogenetic and molecular diagnostic services, including hereditary disease testing. Closely comparable to Bioarray as a domestic Spanish peer in molecular genetic diagnostics.
  • Reference Laboratory S.L. Spanish reference diagnostics laboratory providing specialized molecular and genetic testing to clinicians and hospitals. Directly comparable as a Spain-based molecular diagnostics service provider.
  • Igenomix: Spain-based reproductive and clinical genetics laboratory (now part of Vitrolife) offering molecular diagnostics in reproductive health and hereditary disease. Direct peer due to overlapping molecular genetic testing services and Spanish footprint.

Emerging players

  • Veritas Genetics: Genetics company offering whole-genome and molecular genetic testing with a focus on hereditary disease prevention. Comparable as a genetic disease diagnostics player, though focused on whole-genome sequencing rather than array-based testing.

Regional players

  • Medicover Genetics: European clinical genetics laboratory (part of Medicover) offering molecular and cytogenetic diagnostic services across Central and Eastern Europe. Comparable as a regional molecular diagnostics provider with a hereditary disease focus.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat1 record

Key risks4 records

Key highlights4 records

Customer concentration

Bioarray social profiles

Digital presence

Bioarray financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Bioarray leadership team

Management profile

Number of profiles

Bioarray funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Bioarray M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bioarray

What does Bioarray do?

Bioarray provides molecular diagnosis of genetic diseases. The company operates as a small laboratory services provider focused on identifying and characterizing hereditary and genetic disorders through molecular-level testing. Specific assay menus, panels, or service workflows are not detailed in the available source material.

Is Bioarray a public or private company?

Bioarray is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Bioarray founded?

Bioarray was founded in 2008. It employs 51 to 100 people.

Where is Bioarray based?

Bioarray is headquartered in Elche, Spain, in the Europe region.

Who are Bioarray's main competitors?

Broad incumbents on record are Natera, Myriad Genetics, Eurofins Genomics and Invitae. Direct peers are Centogene, Sistemas Genómicos, Reference Laboratory S.L. and Igenomix. Veritas Genetics is listed as an emerging player. Medicover Genetics is listed as a regional player.

Does Bioarray have an API?

No public API is recorded for Bioarray.

What industry is Bioarray in?

Bioarray's product category is Molecular Diagnostics. Its primary akta.pro industry code is HLAFAMAE, Molecular Diagnostics & Genomics Laboratories, with a secondary code of HLAAALAA, Molecular Diagnostics (PCR/qPCR, NGS-based assays). Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales